MIRA Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of MIRA Pharmaceuticals generated cash of -$4,532, which is more than the previous year. Cash used in financing activities reached the amount of $8,783 last year. Net change in cash is therefore $4,251.
Cash Flow
| 2020 | -203 | 0 | 213 |
|---|---|---|---|
| 2021 | -1.37M | 0 | 4.18M |
| 2022 | -5.60M | 0 | 3.14M |
| 2023 | -4.53K | 0 | 8.78K |
MIRA Cash Flow Statement (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Cash at beginning of period | 350 | 2.80M | 3.49K | 364 |
Operating activities | ||||
Net income | -11.98K | -7.05M | -2.17M | -203 |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 732.29K | 0 | 0 | 0 |
Stock-based compensation expense | 2.55M | 1.29M | 0 | 0 |
| Deferred income tax benefit | 2.55M | 1.29M | 0 | 0 |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | -11 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 |
Accounts payable | -389.52K | 0 | 0 | 0 |
Cash generated by operating activities | -4.53K | -5.60M | -1.37M | -203 |
Investing activities | ||||
Purchases Of Investments | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 |
Financing activities | ||||
Common Stock Issued | 7.70M | 2.90M | 4.5M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -160K | -203.06K | -90K |
Cash used in financing activities | 8.78K | 3.14M | 4.18M | 213 |
Net Change In Cash | 4.25K | -2.45M | 2.80M | 3.12K |
Cash at end of period | 4.60K | 350.97K | 2.80M | 3.49K |
| Data source |